Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information
Using an electrophoretic method, the changes in the catalytic activities of three CK-MM isoforms (MM1, MM2, MM3) and two CK-MB isoforms (MB1, MB2) in the serum of 13 patients with acute myocardial infarction (AMI) have been monitored for 3 days after the onset of chest pain. In post-AMI period, MM3...
Gespeichert in:
Veröffentlicht in: | Scandinavian journal of clinical and laboratory investigation 1987-06, Vol.47 (4), p.325-329 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 329 |
---|---|
container_issue | 4 |
container_start_page | 325 |
container_title | Scandinavian journal of clinical and laboratory investigation |
container_volume | 47 |
creator | PANTEGHINI, M CALARCO, M |
description | Using an electrophoretic method, the changes in the catalytic activities of three CK-MM isoforms (MM1, MM2, MM3) and two CK-MB isoforms (MB1, MB2) in the serum of 13 patients with acute myocardial infarction (AMI) have been monitored for 3 days after the onset of chest pain. In post-AMI period, MM3 reaches a peak first, 17 h after infarction (394 U/l), followed by MB2 (17.3 h, 190 U/l), MB1 (20.6 h, 82 U/l), MM2 (28.7 h, 637 U/l), and MM1 (32 h, 780 U/l). According to their faster decay from circulation, MB2 and MM3 have higher fractional disappearance rates (-0.035 and -0.026 per hour, respectively). The MM3/MM1 activity ratio rises beyond the upper limit found in healthy subjects within about 3 h after onset of symptoms and peaks 9.3 h after AMI, even earlier than peaks of isoforms. These characteristics make the ratio an earlier and more sensitive indicator of acute enzyme release from necrotic myocardium. |
doi_str_mv | 10.3109/00365518709168909 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77608641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77608641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c257t-ca2a8d789362e4459dd0565392923483ee5e685146aedfdcd99ac21959eeacdd3</originalsourceid><addsrcrecordid>eNplkc9u1DAQhy1EVZa2D8AByQfUEyn-Ezv2sVQFKnXFAXqOpvaEGhI7tROkfQpeGS9d9cLJGn-_-Ub2EPKGswvJmf3AmNRKcdMxy7WxzL4gG66YaDpt9Euy2fOmBuQr8rqUn6zW0rTH5FhqJiznG_LnG-Z1oqGkIeWp0DRQlxGWEJH-ChEK0u2WQvR0-5GGSKddcpB9gLFWA2S3hBQv6GWkMM8ZQqmgOh5XiEtYquc3vqduDDG4SvaeGZaHND_sSkhj-vHvuprqcNirTsnRAGPBs8N5Qu4-XX-_-tLcfv18c3V52zihuqVxIMD4zlipBbatst4zpZW0wgrZGomoUBvFWw3oB--8teAEt8oigvNenpDzJ--c0-OKZemnUByOI0RMa-m7TjOjW16D_Cnociol49DPOUyQdz1n_X4J_X9LqD1vD_L1fkL_3HH49crfHTiU-v4hQ3ShPMe6VtRcJ_8CBySQ7w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77608641</pqid></control><display><type>article</type><title>Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information</title><source>MEDLINE</source><source>Taylor & Francis:Master (3349 titles)</source><source>Taylor & Francis Medical Library - CRKN</source><creator>PANTEGHINI, M ; CALARCO, M</creator><creatorcontrib>PANTEGHINI, M ; CALARCO, M</creatorcontrib><description>Using an electrophoretic method, the changes in the catalytic activities of three CK-MM isoforms (MM1, MM2, MM3) and two CK-MB isoforms (MB1, MB2) in the serum of 13 patients with acute myocardial infarction (AMI) have been monitored for 3 days after the onset of chest pain. In post-AMI period, MM3 reaches a peak first, 17 h after infarction (394 U/l), followed by MB2 (17.3 h, 190 U/l), MB1 (20.6 h, 82 U/l), MM2 (28.7 h, 637 U/l), and MM1 (32 h, 780 U/l). According to their faster decay from circulation, MB2 and MM3 have higher fractional disappearance rates (-0.035 and -0.026 per hour, respectively). The MM3/MM1 activity ratio rises beyond the upper limit found in healthy subjects within about 3 h after onset of symptoms and peaks 9.3 h after AMI, even earlier than peaks of isoforms. These characteristics make the ratio an earlier and more sensitive indicator of acute enzyme release from necrotic myocardium.</description><identifier>ISSN: 0036-5513</identifier><identifier>EISSN: 1502-7686</identifier><identifier>DOI: 10.3109/00365518709168909</identifier><identifier>PMID: 3602911</identifier><identifier>CODEN: SJCLAY</identifier><language>eng</language><publisher>Oslo: Scandinavian University Press</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Cardiology. Vascular system ; Coronary heart disease ; Creatine Kinase - blood ; Female ; Heart ; Humans ; Isoenzymes ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - enzymology ; Myocardial Infarction - physiopathology ; Prognosis</subject><ispartof>Scandinavian journal of clinical and laboratory investigation, 1987-06, Vol.47 (4), p.325-329</ispartof><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c257t-ca2a8d789362e4459dd0565392923483ee5e685146aedfdcd99ac21959eeacdd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7420297$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3602911$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PANTEGHINI, M</creatorcontrib><creatorcontrib>CALARCO, M</creatorcontrib><title>Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information</title><title>Scandinavian journal of clinical and laboratory investigation</title><addtitle>Scand J Clin Lab Invest</addtitle><description>Using an electrophoretic method, the changes in the catalytic activities of three CK-MM isoforms (MM1, MM2, MM3) and two CK-MB isoforms (MB1, MB2) in the serum of 13 patients with acute myocardial infarction (AMI) have been monitored for 3 days after the onset of chest pain. In post-AMI period, MM3 reaches a peak first, 17 h after infarction (394 U/l), followed by MB2 (17.3 h, 190 U/l), MB1 (20.6 h, 82 U/l), MM2 (28.7 h, 637 U/l), and MM1 (32 h, 780 U/l). According to their faster decay from circulation, MB2 and MM3 have higher fractional disappearance rates (-0.035 and -0.026 per hour, respectively). The MM3/MM1 activity ratio rises beyond the upper limit found in healthy subjects within about 3 h after onset of symptoms and peaks 9.3 h after AMI, even earlier than peaks of isoforms. These characteristics make the ratio an earlier and more sensitive indicator of acute enzyme release from necrotic myocardium.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Coronary heart disease</subject><subject>Creatine Kinase - blood</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Isoenzymes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - enzymology</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Prognosis</subject><issn>0036-5513</issn><issn>1502-7686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkc9u1DAQhy1EVZa2D8AByQfUEyn-Ezv2sVQFKnXFAXqOpvaEGhI7tROkfQpeGS9d9cLJGn-_-Ub2EPKGswvJmf3AmNRKcdMxy7WxzL4gG66YaDpt9Euy2fOmBuQr8rqUn6zW0rTH5FhqJiznG_LnG-Z1oqGkIeWp0DRQlxGWEJH-ChEK0u2WQvR0-5GGSKddcpB9gLFWA2S3hBQv6GWkMM8ZQqmgOh5XiEtYquc3vqduDDG4SvaeGZaHND_sSkhj-vHvuprqcNirTsnRAGPBs8N5Qu4-XX-_-tLcfv18c3V52zihuqVxIMD4zlipBbatst4zpZW0wgrZGomoUBvFWw3oB--8teAEt8oigvNenpDzJ--c0-OKZemnUByOI0RMa-m7TjOjW16D_Cnociol49DPOUyQdz1n_X4J_X9LqD1vD_L1fkL_3HH49crfHTiU-v4hQ3ShPMe6VtRcJ_8CBySQ7w</recordid><startdate>19870601</startdate><enddate>19870601</enddate><creator>PANTEGHINI, M</creator><creator>CALARCO, M</creator><general>Scandinavian University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19870601</creationdate><title>Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information</title><author>PANTEGHINI, M ; CALARCO, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c257t-ca2a8d789362e4459dd0565392923483ee5e685146aedfdcd99ac21959eeacdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Coronary heart disease</topic><topic>Creatine Kinase - blood</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Isoenzymes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - enzymology</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PANTEGHINI, M</creatorcontrib><creatorcontrib>CALARCO, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of clinical and laboratory investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PANTEGHINI, M</au><au>CALARCO, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information</atitle><jtitle>Scandinavian journal of clinical and laboratory investigation</jtitle><addtitle>Scand J Clin Lab Invest</addtitle><date>1987-06-01</date><risdate>1987</risdate><volume>47</volume><issue>4</issue><spage>325</spage><epage>329</epage><pages>325-329</pages><issn>0036-5513</issn><eissn>1502-7686</eissn><coden>SJCLAY</coden><abstract>Using an electrophoretic method, the changes in the catalytic activities of three CK-MM isoforms (MM1, MM2, MM3) and two CK-MB isoforms (MB1, MB2) in the serum of 13 patients with acute myocardial infarction (AMI) have been monitored for 3 days after the onset of chest pain. In post-AMI period, MM3 reaches a peak first, 17 h after infarction (394 U/l), followed by MB2 (17.3 h, 190 U/l), MB1 (20.6 h, 82 U/l), MM2 (28.7 h, 637 U/l), and MM1 (32 h, 780 U/l). According to their faster decay from circulation, MB2 and MM3 have higher fractional disappearance rates (-0.035 and -0.026 per hour, respectively). The MM3/MM1 activity ratio rises beyond the upper limit found in healthy subjects within about 3 h after onset of symptoms and peaks 9.3 h after AMI, even earlier than peaks of isoforms. These characteristics make the ratio an earlier and more sensitive indicator of acute enzyme release from necrotic myocardium.</abstract><cop>Oslo</cop><pub>Scandinavian University Press</pub><pmid>3602911</pmid><doi>10.3109/00365518709168909</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0036-5513 |
ispartof | Scandinavian journal of clinical and laboratory investigation, 1987-06, Vol.47 (4), p.325-329 |
issn | 0036-5513 1502-7686 |
language | eng |
recordid | cdi_proquest_miscellaneous_77608641 |
source | MEDLINE; Taylor & Francis:Master (3349 titles); Taylor & Francis Medical Library - CRKN |
subjects | Adult Aged Biological and medical sciences Cardiology. Vascular system Coronary heart disease Creatine Kinase - blood Female Heart Humans Isoenzymes Male Medical sciences Middle Aged Myocardial Infarction - enzymology Myocardial Infarction - physiopathology Prognosis |
title | Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T00%3A14%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20isoforms%20of%20creatine%20kinase%20MM%20and%20MB%20in%20myocardial%20infarction.%20An%20appraisal%20of%20quantitative,%20clinical%20and%20pathophysiological%20information&rft.jtitle=Scandinavian%20journal%20of%20clinical%20and%20laboratory%20investigation&rft.au=PANTEGHINI,%20M&rft.date=1987-06-01&rft.volume=47&rft.issue=4&rft.spage=325&rft.epage=329&rft.pages=325-329&rft.issn=0036-5513&rft.eissn=1502-7686&rft.coden=SJCLAY&rft_id=info:doi/10.3109/00365518709168909&rft_dat=%3Cproquest_cross%3E77608641%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77608641&rft_id=info:pmid/3602911&rfr_iscdi=true |